Dr Benedict Brönnimann is a seasoned executive and has been managing medtech and pharmaceutical companies for more than 20 years. He has a history of success in delivering strong results for companies in medical device and pharmaceutical industries both in Europe and the USA. Prior to OstomyCure he was Senior Partner at Rosewall Ventures Ltd, President and CEO of Leman Cardiovascular SA and Hancock Laboratories Inc which recently completed a NASDAQ listing.

Prior to his executive experience, he worked as a certified specialist in both general surgery and pharmaceutical medicine with over 10 years of clinical practice.

Speciality Surgery, Clinical Practice
Degrees M.D. of Medicine
Areas of Expertise
  • Executive management
  • Pharmaceutical Medicine
  • Medical Strategy
Office Switzerland
Gender Male